Cc1ccc(-n2nc3c(c2NC(=O)c2ccc4c(c2)OCO4)C[S+]([O-])C3)c(C)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?